Protection against Th17 Cells Differentiation by an Interleukin-23 Receptor Cytokine-Binding Homology Region

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Guo, Wei ^a   Luo, Cheng ^a   Wang, Chen ^a   Zhu, Yue ^a   Wang, Xin ^a   Gao, Xiangdong ^a   Yao, Wenbing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; RETINOIC ACID RECEPTOR GAMMA; RETINOIC ACID RECEPTOR GAMMA T; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; TH17 CELL;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; HUMANS; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN; TH17 CELLS;

MUS;

EID: 84866541875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045625     Document Type: Article

References (38)

1. Dong X, Foteinou PT, Calvano SE, Lowry SF, Androulakis IP, (2010) Agent-based modeling of endotoxin-induced acute inflammatory response in human blood leukocytes. PLoS One 5: e9249.
2. Serhan CN, Ward PA, Gilroy DW (2010) Fundamentals of inflammation. Cambridge; New York: Cambridge University Press. xiv, 473 p.
3. Balkwill F, Mantovani A, (2001) Inflammation and cancer: back to Virchow? The Lancet 357: 539-545.
4. Zhu J, Paul WE, (2010) Heterogeneity and plasticity of T helper cells. Cell Res 20: 4-12.
5. Zhu J, Yamane H, Paul WE, (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28: 445-489.
6. Nikoopour E, Schwartz JA, Singh B, (2008) Therapeutic benefits of regulating inflammation in autoimmunity. Inflamm Allergy Drug Targets 7: 203-210.
7. Weaver CT, Murphy KM, (2007) The central role of the Th17 lineage in regulating the inflammatory/autoimmune axis. Semin Immunol 19: 351-352.
8. Zhang L, Yuan S, Cheng G, Guo B, (2011) Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS One 6: e28432.
9. Turner JE, Paust HJ, Steinmetz OM, Panzer U, (2010) The Th17 immune response in renal inflammation. Kidney Int 77: 1070-1075.
10. Iwakura Y, Ishigame H, (2006) The IL-23/IL-17 axis in inflammation. J Clin Invest 116: 1218-1222.
11. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR, (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6: 169-175.
12. Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M, (2008) Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 226: 87-102.
13. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B, (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
14. Stockinger B, Veldhoen M, (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19: 281-286.
15. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
16. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168: 5699-5708.
17. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL, (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278: 1910-1914.
18. McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, et al. (2009) The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10: 314-324.
19. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
20. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
21. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, et al. (2006) Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116: 1317-1326.
22. LaVallie ER, Rehemtulla A, Racie LA, DiBlasio EA, Ferenz C, et al. (1993) Cloning and functional expression of a cDNA encoding the catalytic subunit of bovine enterokinase. J Biol Chem 268: 23311-23317.
23. Stewart EJ, Aslund F, Beckwith J, (1998) Disulfide bond formation in the Escherichia coli cytoplasm: an in vivo role reversal for the thioredoxins. EMBO J 17: 5543-5550.
24. Chi W, Yang P, Li B, Wu C, Jin H, et al. (2007) IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 119: 1218-1224.
25. Frauwirth KA, Thompson CB, (2002) Activation and inhibition of lymphocytes by costimulation. J Clin Invest 109: 295-299.
26. Bouguermouh S, Fortin G, Baba N, Rubio M, Sarfati M, (2009) CD28 co-stimulation down regulates Th17 development. PLoS One 4: e5087.
27. Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ, (2007) Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 56: 2936-2946.
28. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM, (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
29. Ouyang W, Kolls JK, Zheng Y, (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467.
30. Awasthi A, Kuchroo VK, (2009) Th17 cells: from precursors to players in inflammation and infection. Int Immunol 21: 489-498.
31. Langrish CL, (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
32. Suen KF, Turner MS, Gao F, Liu B, Althage A, et al. (2010) Transient expression of an IL-23R extracellular domain Fc fusion protein in CHO vs. HEK cells results in improved plasma exposure. Protein Expr Purif 71: 96-102.
33. Yu RY, Gallagher G, (2010) A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells. J Immunol 185: 7302-7308.
34. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, et al. (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282: 9358-9363.
35. Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, et al. (2006) STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 176: 5652-5661.
36. Caruso R, Fina D, Paoluzi OA, Del Vecchio Blanco G, Stolfi C, et al. (2008) IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 38: 470-478.
37. Ivanov, II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
38. Cornelissen F, Mus AM, Asmawidjaja PS, van Hamburg JP, Tocker J, et al. (2009) Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells. Arthritis Res Ther 11: R194.